Invokana (canagliflozin)

pCPA File Number: 20744
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
SR0370-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: